Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADAR: Rituximab 200mg vs 1g Maintenance in RA
NCT06906549Phase 4Recruiting
- Sponsor
- Strasbourg University Hospital
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in rheumatoid arthritis (RA), sponsored by Strasbourg University Hospital. Started Jul 2025; status: recruiting.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06906549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06906549.